A new study reveals that many perceived benefits of gluten-free products, such as weight control and diabetes management, are ...

Pfizer has made the decision to discontinue the clinical development program for danuglipron, an oral GLP-1 receptor agonist, being investigated for chronic weight management.

The prevalence of irritable bowel syndrome and chronic idiopathic constipation rose significantly during the COVID-19 pandemic.

Hormone diets have taken off on social media as the latest weight loss trend, but their scientific validity remains ...

Thanks for visiting Gastroenterology Advisor. We hope you’re enjoying the latest clinical news, full-length features, case studies, and more. You’ve view ...

Incidental BE was common and associated with high-risk features that were similar to or more severe than those found in BE diagnosed by traditional methods.

HealthDay News — The viability of hospital-based emergency care in the United States is at risk, according to a RAND report released April 7.

More than 150 million Americans might lose no-cost access to preventive care services under a case being heard at the US Supreme Court.

Adverse pregnancy outcomes mediate a small proportion of the association between prepregnancy obesity and CVD risk in midlife.

PBGENE-HBV is designed to potentially cure chronic hepatitis B by eliminating the root cause of the virus. The Food and Drug Administration (FDA) has granted Fast Track designation to PBGENE-HBV, an ...

The Trump administration is weighing a plan to cut nearly a third of the federal health budget and eliminate dozens of programs.